treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: Comparison of imatinib 400 mg and 800 mg daily in the front-line
2010
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
41
References
0
Citations
NaN
KQI